Guest Editorial The Russian invasion of Ukraine:Implication for hematologists and oncologists February 25, 2022Vol.48 No.08By Robert Peter Gale
Guest Editorial Congressional inaction harms federally funded oncology research and our patients:The time for the cancer community to act is now February 04, 2022Vol.48 No.05By Howard A. "Skip" Burris III, Charles D. Blanke, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Douglas S. Hawkins, Quynh-Thu Le, Robert S. Mannel, Norman Wolmark and Janet Dancey
Guest Editorial Novel mentorship program tackles disparities in clinical research January 28, 2022Vol.48 No.04By Roy S. Herbst, Yu Shyr and Robert A. Winn
FreeGuest Editorial Congress, Biden have an opportunity to invest in cancer research today for better treatments, cures tomorrow January 21, 2022Vol.48 No.03By David A. Tuveson
COVID-19 & CancerGuest Editorial Omicron: Is the light at the end of the tunnel (a) pandemic salvation, or (b) an oncoming freight train? January 14, 2022Vol.48 No.02By Jeremy L. Warner and Sanjay Mishra
Guest Editorial Symposium focuses on racism in health care and public health—from Nazi medicine to COVID and cancer January 07, 2022Vol.48 No.01By Arthur L. Caplan
Guest EditorialHealth Equity To make clinical trials equitable, cancer groups evaluate restrictive eligibility criteria November 19, 2021Vol.47 No.43By Julia Beaver, Thomas S. Uldrick, Gwynn Ison, Suanna S. Bruinooge, Caroline Schenkel and Edward S. Kim
Guest Editorial Jill Biden’s visit to Hollings brings awareness to mammograms missed during the pandemic October 29, 2021Vol.47 No.40By Raymond N. DuBois
Cancer History ProjectFreeGuest Editorial Tackling health equity and Latinx representation in medicine as U.S. Hispanic population grows October 15, 2021Vol.47 No.38By Ana Maria López
